Zanuburutinib in Relapsed and Refractory iMCD: a Prospective, Single-center, Single-arm Trial

A Study of Anti-IL-6R mAb Injection in Patients With iMCD

NCT05345522 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD

NCT06405100 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment

NCT01183598 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing Myopathy

NCT04025632 ·Status: TERMINATED ·Phase: PHASE2

Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy

NCT05833711 ·Status: UNKNOWN ·Phase: PHASE2

Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)

NCT06180278 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

The Safety and Tolerability of CLZ-2002 in Patients With Charcot-Marie Tooth Disease.

NCT05947578 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis

NCT07039578 ·Status: RECRUITING ·Phase: PHASE2

A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

NCT06698796 ·Status: RECRUITING ·Phase: PHASE3

A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases

NCT07284797 ·Status: RECRUITING ·Phase: PHASE1

Study of CM313 in Subject With IgA Nephropathy

NCT06830395 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia

NCT05640102 ·Status: RECRUITING

Producing a Novel Symptom Burden Scale for People Living With Idiopathic Multicentric Castleman Disease (ISBUS)

NCT05995834 ·Status: UNKNOWN

Study to Evaluate the Efficacy and Safety of CM310 in Subjects With IgG4-related Disease

NCT05728684 ·Status: UNKNOWN ·Phase: NA

Ruxolitinib Treatment in Inclusion Body Myositis

NCT06536166 ·Status: RECRUITING ·Phase: PHASE2

Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

NCT04561557 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

NCT07103746 ·Status: RECRUITING ·Phase: PHASE2

Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms

NCT00487708 ·Status: COMPLETED ·Phase: PHASE2

Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD

NCT04717635 ·Status: COMPLETED ·Phase: PHASE3

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

NCT03499808 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI

NCT03153319 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

NCT06561347 ·Status: RECRUITING ·Phase: PHASE2

First in Human Study of EI-001 Monoclonal Antibody in Healthy Volunteers

NCT04994912 ·Status: COMPLETED ·Phase: PHASE1

A Study of Mirikizumab in Healthy Chinese Participants

NCT04137380 ·Status: COMPLETED ·Phase: PHASE1

MEmbranous Nephropathy Trial Of Rituximab

NCT01180036 ·Status: COMPLETED ·Phase: PHASE2/PHASE3